Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mahdi Zirakchian Zadeh

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|August 9, 2023
Clinical Application of <sup>18</sup>F-FDG-PET Quantification in Hematological Malignancies: Emphasizing Multiple Myeloma, Lymphoma and Chronic Lymphocytic LeukemiaMahdi Zirakchian Zadeh
Clinical & Experimental Metastasis|September 8, 2023
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on <sup>18</sup>F-FDGMahdi Zirakchian Zadeh
Bone|November 16, 2023
The role of conventional and novel PET radiotracers in assessment of myeloma bone diseaseMahdi Zirakchian Zadeh
Annals of Nuclear Medicine|May 25, 2026
Is It time to move beyond FDG toward a more specific yet broadly applicable radiotracer such as FAPI? why yes-and why notMahdi Zirakchian Zadeh
Clinical Nuclear Medicine|February 15, 2019
An Isolated Osseous Rosai-Dorfman Disease Shown on FDG PET/CTMahdi Zirakchian Zadeh, Zhe Wen, Lisa J States, et al.
PET Clinics|September 2, 2019
The Evolving Role of PET-Based Novel Quantitative Techniques in the Interventional Radiology Procedures of the LiverSiavash Mehdizadeh Seraj, Cyrus Ayubcha, Mahdi Zirakchian Zadeh, et al.
Nuclear Medicine Communications|February 1, 2022
A review of different methods used for quantification and assessment of FDG-PET/CT in multiple myelomaMahdi Zirakchian Zadeh, Cyrus Ayubcha, William Y Raynor, et al.
PET Clinics|May 16, 2019
Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological MalignanciesWilliam Y Raynor, Mahdi Zirakchian Zadeh, Esha Kothekar, et al.
PET Clinics|November 14, 2018
Metastatic Seeding Attacks Bone Marrow, Not Bone: Rectifying Ongoing MisconceptionsWilliam Y Raynor, Abdullah Al-Zaghal, Mahdi Zirakchian Zadeh, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 28, 2019
Pretreatment volumetric parameters of FDG-PET predict the survival after Yttrium-90 radio-embolization in metastatic liver diseaseSiavash Mehdizadeh Seraj, Mahdi Zirakchian Zadeh, Thomas J Werner, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Clinical Lymphoma, Myeloma & Leukemia|August 9, 2023
Clinical Application of <sup>18</sup>F-FDG-PET Quantification in Hematological Malignancies: Emphasizing Multiple Myeloma, Lymphoma and Chronic Lymphocytic LeukemiaMahdi Zirakchian Zadeh
Clinical & Experimental Metastasis|September 8, 2023
PET/CT in assessment of colorectal liver metastases: a comprehensive review with emphasis on <sup>18</sup>F-FDGMahdi Zirakchian Zadeh
Bone|November 16, 2023
The role of conventional and novel PET radiotracers in assessment of myeloma bone diseaseMahdi Zirakchian Zadeh
Annals of Nuclear Medicine|May 25, 2026
Is It time to move beyond FDG toward a more specific yet broadly applicable radiotracer such as FAPI? why yes-and why notMahdi Zirakchian Zadeh
Clinical Nuclear Medicine|February 15, 2019
An Isolated Osseous Rosai-Dorfman Disease Shown on FDG PET/CTMahdi Zirakchian Zadeh, Zhe Wen, Lisa J States, et al.
PET Clinics|September 2, 2019
The Evolving Role of PET-Based Novel Quantitative Techniques in the Interventional Radiology Procedures of the LiverSiavash Mehdizadeh Seraj, Cyrus Ayubcha, Mahdi Zirakchian Zadeh, et al.
Nuclear Medicine Communications|February 1, 2022
A review of different methods used for quantification and assessment of FDG-PET/CT in multiple myelomaMahdi Zirakchian Zadeh, Cyrus Ayubcha, William Y Raynor, et al.
PET Clinics|May 16, 2019
Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological MalignanciesWilliam Y Raynor, Mahdi Zirakchian Zadeh, Esha Kothekar, et al.
PET Clinics|November 14, 2018
Metastatic Seeding Attacks Bone Marrow, Not Bone: Rectifying Ongoing MisconceptionsWilliam Y Raynor, Abdullah Al-Zaghal, Mahdi Zirakchian Zadeh, et al.
American Journal of Nuclear Medicine and Molecular Imaging|November 28, 2019
Pretreatment volumetric parameters of FDG-PET predict the survival after Yttrium-90 radio-embolization in metastatic liver diseaseSiavash Mehdizadeh Seraj, Mahdi Zirakchian Zadeh, Thomas J Werner, et al.
Pageof 4